Keith C Ferdinand
Overview
Explore the profile of Keith C Ferdinand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
250
Citations
4781
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ayesh H, Nasser S, Ferdinand K, Carranza Leon B
Circ Res
. 2025 Mar;
136(6):594-605.
PMID: 40080532
Obesity in women is a significant public health issue with serious implications for cardiovascular-kidney-metabolic syndrome and cardiovascular disease. This complex challenge is influenced by physiological, hormonal, socioeconomic, and cultural factors....
2.
Flack J, Schlaich M, Weber M, Sassi-Sayadi M, Narkiewicz K, Clozel M, et al.
Hypertension
. 2025 Jan;
PMID: 39840441
Background: Black individuals frequently present with resistant hypertension and disproportionately increased cardiovascular risk. We investigated the blood pressure (BP)-lowering effect of the dual endothelin receptor antagonist aprocitentan in Black individuals...
3.
Ferdinand K
Am J Manag Care
. 2024 Dec;
30(10 Suppl):S181-S188.
PMID: 39705194
Cardio-kidney-metabolic (CKM) syndrome is a term to describe the interconnection between cardiovascular disease, type 2 diabetes, and chronic kidney disease. The National Health and Nutrition Examination Survey from 1999 to...
4.
5.
Bond R, Bello N, Ansong A, Ferdinand K
Am Heart J Plus
. 2024 Sep;
46:100445.
PMID: 39319102
Hypertension is one of the leading risk factors for cardiovascular disease. The ACC/AHA/Multisociety hypertension guideline covered all aspects of the recommendations for optimal blood pressure diagnosis and management to improve...
6.
Reddy T, Villavaso C, Pulapaka A, Ferdinand K
Am Heart J Plus
. 2024 Sep;
46:100455.
PMID: 39315291
The role of incretin-based therapies, including glucagon-like peptide-1 receptor agonists (GLP1RAs) and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, in the management of type 2 diabetes mellitus (T2DM) and obesity...
7.
Reddy T, Nasser S, Pulapaka A, Gistand C, Ferdinand K
Curr Cardiol Rep
. 2024 Sep;
26(11):1163-1171.
PMID: 39235728
Purpose Of Review: Elevated blood pressure is the leading modifiable risk factor for cardiovascular morbidity and mortality in the US. Older individuals, Black adults, and those with comorbidities such as...
8.
Cluett J, Blazek O, Brown A, East C, Ferdinand K, Fisher N, et al.
Hypertension
. 2024 Aug;
81(10):e135-e148.
PMID: 39101202
Hypertension is a leading risk factor for cardiovascular morbidity and mortality. Despite the widespread availability of both pharmacological and lifestyle therapeutic options, blood pressure control rates across the globe are...
9.
Nasser S, Arora N, Ferdinand K
Rev Cardiovasc Med
. 2024 Jul;
23(12):411.
PMID: 39076675
The racial/ethnic disparities in cardiometabolic risk factors and cardiovascular diseases (CVD) are prominent in non-Hispanic Black adults and other United States (U.S.) sub-populations, with evidence of differential access and quality...
10.